Expert Analysis

Top 5 Antitrust Issues For In-House Counsel To Watch In 2026

With Trump administration enforcement policy having largely taken shape last year, antitrust issues that in-house ... (more story)

2025 Legal Milestones That Will Shape Psychedelics Sector

As 2025 draws to a close, psychedelic drug development stands at an inflection point, experiencing unprecedented m... (more story)

2025 State AI Laws Expand Liability, Raise Insurance Risks

As 2025 nears its end, claims professionals should be aware of trends in state legislation addressing artificial i... (more story)

Deals & Corporate Governance More

AdaptHealth To Pay Investors $35M To End Inflated-Sales Suit

Medical device provider AdaptHealth Corp. has agreed to pay $35 million to settle a lawsuit accusing it of deceiving shareholders about its revenue projections as it "routinely engaged in improper and unethica... (more story)

Top North Carolina Cases Of 2025

A sweep of settlements in major lawsuits punctuated the second half of the year in North Carolina, from a record-breaking wrongful death deal to an eleventh-hour resolution in a lending fight over a biogas dev... (more story)

New Class Action Claims CIBC, RBC Rigged Quantum Shares

A Quantum Biopharma investor has filed a proposed class action against several major Canadian banks, accusing them of running a spoofing scheme for years that artificially drove down Quantum's stock price — fl... (more story)

Taxation With Representation: Baker Botts, Morgan Lewis

In this week's Taxation With Representation, Trump Media and Technology Group merges with fusion power company TAE Technologies, pharmaceutical company Cencora boosts its stake in cancer care company OneOncolo... (more story)

Biomedical Co. Gets Approval For Ch. 11 Auction In January

Eye disease treatment developer Clearside Biomedical on Friday got permission from a Delaware bankruptcy judge for a January auction of its assets after saying it had resolved objections from shareholders and ... (more story)

BioMarin Inks $4.8B Amicus Buy As Patent Litigation Resolved

BioMarin Pharmaceutical Inc. has agreed to acquire Amicus Therapeutics for $4.8 billion, in a deal bolstered by Amicus' settlement of patent litigation that secures U.S. exclusivity for its Galafold drug until... (more story)

Digital Health & Technology More

The High-Stakes Healthcare AI Battles To Watch In 2026

Courts across the country are set to hear a wave of litigation in the coming year that will begin to draw the legal boundaries around artificial intelligence in healthcare and the life sciences. Law360 spoke w... (more story)

Patients Say Pa. Med Mal Firm Left Data Vulnerable To Hackers

A Pittsburgh law firm that handles medical malpractice and insurance litigation faces a proposed class action complaint alleging that it failed to protect the private health and personal data of patients whose... (more story)

Colo. IVF Co. Says AI Fertility Co. Owes Nearly $900K

The maker of an in vitro fertilization incubator system has filed a breach of contract lawsuit in Colorado federal court, claiming an artificial intelligence-based fertility company owes it nearly $900,000 for... (more story)

ITC Clears Toy Gun Imports, Will Review Smart Rings, Vapes

The U.S. International Trade Commission has had a busy week in intellectual property, determining a series of toy gun imports don't infringe Spin Master patents licensed to Hasbro, instituting reviews requeste... (more story)

Late Plaintiff Substitutions Sink Hospital Health Data Suit

A Pennsylvania federal judge has dismissed a proposed data breach class action against Thomas Jefferson University Hospitals Inc. over the named plaintiffs purported inability to serve as leaders of the suit, ... (more story)

Epic Systems Is Monopolizing EHR Market, Texas AG Suit Says

Texas Attorney General Ken Paxton hit Epic Systems Corp. with an antitrust suit in state court on Wednesday alleging the company is illegally seeking to monopolize markets for electronic health records software.

Policy & Compliance More

Drug Pricing Battles To Watch In 2026

With drugmakers already pushing back on drug affordability programs and policies, Law360 looks at the year ahead for litigation focused on state and federal drug pricing programs.

NC Legislation To Watch In 2026: Healthcare Funding In Focus

A spate of healthcare legislation is on the line as North Carolina lawmakers get ready to return to the General Assembly in January, from tenuous funding for Medicaid and Planned Parenthood to efforts to contr... (more story)

New Jersey Cases To Watch In 2026

In the coming year, New Jersey litigators will be watching for the outcome of an appeal in a constitutional challenge to school segregation and an employment discrimination case brought by a former Johnson & J... (more story)

Pennsylvania Cases To Watch In 2026

As winter's chill rings in the new year, several high-profile cases are set to heat up Pennsylvania's dockets in 2026, including disciplinary charges against a judge associated with rapper Meek Mill, a pending... (more story)

4 High Court Cases To Watch This Spring

The U.S. Supreme Court justices will return from the winter holidays to tackle several constitutional disputes that range from who is entitled to birthright citizenship to whether transgender individuals are e... (more story)

Trump Admin Beats Chamber Suit Over $100K H-1B Visa Fee

A Washington, D.C., federal judge on Tuesday refused to block the Trump administration's new $100,000 H-1B visa fee, ruling in the U.S. Chamber of Commerce's lawsuit challenging the fee that President Donald T... (more story)